Polaryx Therapeutics to Participate in NTSAD Annual Family Conference
Polaryx Therapeutics (PLYX) will participate in the National Tay-Sachs & Allied Diseases Association Annual Family Conference, scheduled for April 30 to May 3, 2026. The event provides an opportunity for the company to engage with patients, caregivers, and advocates in the rare disease community and share updates on its clinical development programs, including its lead candidate PLX-200.
Tickers: $PLYX
Topics: biotechnology clinical trials patient engagement rare diseases